Quantbot Technologies LP Sells 114,223 Shares of DENTSPLY SIRONA Inc. $XRAY

Quantbot Technologies LP lessened its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 62.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 68,202 shares of the medical instruments supplier’s stock after selling 114,223 shares during the period. Quantbot Technologies LP’s holdings in DENTSPLY SIRONA were worth $865,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $26,000. Parkside Financial Bank & Trust raised its holdings in shares of DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,477 shares in the last quarter. True Wealth Design LLC raised its holdings in shares of DENTSPLY SIRONA by 273.0% during the second quarter. True Wealth Design LLC now owns 2,376 shares of the medical instruments supplier’s stock valued at $38,000 after acquiring an additional 1,739 shares in the last quarter. Central Pacific Bank Trust Division lifted its stake in DENTSPLY SIRONA by 100.0% in the third quarter. Central Pacific Bank Trust Division now owns 4,000 shares of the medical instruments supplier’s stock worth $51,000 after acquiring an additional 2,000 shares during the period. Finally, Versant Capital Management Inc boosted its holdings in DENTSPLY SIRONA by 878.6% in the third quarter. Versant Capital Management Inc now owns 4,883 shares of the medical instruments supplier’s stock valued at $62,000 after acquiring an additional 4,384 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $12.74 on Friday. DENTSPLY SIRONA Inc. has a 12 month low of $9.85 and a 12 month high of $17.18. The firm has a market capitalization of $2.54 billion, a P/E ratio of -4.25, a P/E/G ratio of 1.56 and a beta of 0.97. The company has a current ratio of 1.51, a quick ratio of 1.03 and a debt-to-equity ratio of 1.50. The business has a fifty day simple moving average of $12.63 and a two-hundred day simple moving average of $12.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). The business had revenue of $961.00 million during the quarter, compared to analysts’ expectations of $926.40 million. DENTSPLY SIRONA had a positive return on equity of 18.85% and a negative net margin of 16.25%.The firm’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.26 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 5.0%. The ex-dividend date was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -21.33%.

Insider Activity

In other news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Barrington Research boosted their price objective on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a research report on Monday, March 2nd. Bank of America raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and raised their target price for the stock from $13.00 to $17.00 in a research report on Thursday, February 19th. JPMorgan Chase & Co. reduced their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, January 21st. Finally, Wells Fargo & Company lifted their price objective on DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average target price of $14.42.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.